India Rejects Abbott Lab’s Patent Application for HIV Drug India Rejects Abbott Lab’s Patent Application for HIV Drug – I-MAK

India Rejects Abbott Lab’s Patent Application for HIV Drug

4 Jan 2011

India has rejected a drug patent application of a US multi-national pharma company, paving way for easy access to an important life-saving medication for HIV patients across the globe. The Economic Times

Partner with us now to build
a more just and equitable
medicine system for all.